Literature DB >> 30158151

Glycoconjugate vaccines: Principles and mechanisms.

Rino Rappuoli1.   

Abstract

Bacterial conjugate vaccines are used in infants, adolescents, and the elderly, and they are among the safest and most successful vaccines developed during the last 40 years. Conjugation of polysaccharides to proteins provides T cell epitopes that are necessary in the germinal centers for the affinity maturation of polysaccharide-specific B cells. Collective analysis of data from animal experiments and clinical trials, reviewed with current knowledge of immunology, revealed possible mechanistic explanations that may improve our understanding of conjugate vaccines. Key conclusions are that naïve infants respond differently from adolescents and adults and that most of recommended schedules generate only 10 to 35% of the maximal antibody titer that the vaccine can induce, indicating that the full potential of glycoconjugate vaccines has not yet been reached.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30158151     DOI: 10.1126/scitranslmed.aat4615

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  49 in total

1.  On the mechanisms of conjugate vaccines.

Authors:  Rino Rappuoli; Ennio De Gregorio; Paolo Costantino
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-21       Impact factor: 11.205

2.  Top-Down Characterization of Lipooligosaccharides from Antibiotic-Resistant Bacteria.

Authors:  Dustin R Klein; Matthew J Powers; M Stephen Trent; Jennifer S Brodbelt
Journal:  Anal Chem       Date:  2019-07-26       Impact factor: 6.986

3.  Immunogenicity Evaluation of N-Glycans Recognized by HIV Broadly Neutralizing Antibodies.

Authors:  Sachin S Shivatare; Ting-Jen Rachel Cheng; Yang-Yu Cheng; Vidya S Shivatare; Tsung-I Tsai; Hong-Yang Chuang; Chung-Yi Wu; Chi-Huey Wong
Journal:  ACS Chem Biol       Date:  2021-08-15       Impact factor: 4.634

Review 4.  Recent progress in chemical synthesis of bacterial surface glycans.

Authors:  Riyao Li; Hai Yu; Xi Chen
Journal:  Curr Opin Chem Biol       Date:  2020-09-11       Impact factor: 8.822

5.  Synthesis of Mannosidase-Stable Man3 and Man4 Glycans Containing S-linked Manα1→2Man Termini.

Authors:  Mahesh Neralkar; Leiming Tian; Richard L Redman; Isaac J Krauss
Journal:  Org Lett       Date:  2021-04-01       Impact factor: 6.005

Review 6.  Recent advances on smart glycoconjugate vaccines in infections and cancer.

Authors:  Marko Anderluh; Francesco Berti; Anna Bzducha-Wróbel; Fabrizio Chiodo; Cinzia Colombo; Federica Compostella; Katarzyna Durlik; Xhenti Ferhati; Rikard Holmdahl; Dragana Jovanovic; Wieslaw Kaca; Luigi Lay; Milena Marinovic-Cincovic; Marco Marradi; Musa Ozil; Laura Polito; Josè Juan Reina; Celso A Reis; Robert Sackstein; Alba Silipo; Urban Švajger; Ondřej Vaněk; Fumiichiro Yamamoto; Barbara Richichi; Sandra J van Vliet
Journal:  FEBS J       Date:  2021-06-01       Impact factor: 5.622

Review 7.  Recent advances in the production of recombinant glycoconjugate vaccines.

Authors:  Emily Kay; Jon Cuccui; Brendan W Wren
Journal:  NPJ Vaccines       Date:  2019-05-01       Impact factor: 7.344

Review 8.  Enzymatic Synthesis of Glycans and Glycoconjugates.

Authors:  Thomas Rexer; Dominic Laaf; Johannes Gottschalk; Hannes Frohnmeyer; Erdmann Rapp; Lothar Elling
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

Review 9.  Hepatitis C Virus Glycan-Dependent Interactions and the Potential for Novel Preventative Strategies.

Authors:  Emmanuelle V LeBlanc; Youjin Kim; Chantelle J Capicciotti; Che C Colpitts
Journal:  Pathogens       Date:  2021-06-01

Review 10.  C-Type Lectin Receptors in Host Defense Against Bacterial Pathogens.

Authors:  Malgorzata E Mnich; Rob van Dalen; Nina M van Sorge
Journal:  Front Cell Infect Microbiol       Date:  2020-07-07       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.